Sort
64,565 grants matching “drug discovery”
Identification of Covalent Transcriptional Dependencies in Melanoma
$697,629Liron Bar-Peled · Massachusetts General Hospital · R01 · FY2024 · CA
Airway epithelial cytoglobin regulates nitric oxide synthase and development of primary ciliary dyskinesia and situs inversus
$697,617Mark Thomas Gladwin · University Of Maryland Baltimore · R01 · FY2025 · HL
Discovering the essential genome of Plasmodium falciparum
$697,594John Adams · University Of South Florida · R01 · FY2018 · AI
Clinical Informatics to Advance Epidemiology and Pharmacogenetics of Serious Cutaneous Adverse Drug Reactions
$697,549Li Zhou · Brigham And Women'S Hospital · R01 · FY2021 · AI
Computational and functional discovery of isoforms driving cancer and drug resistance
$697,535Angela Norie Brooks · University Of California Santa Cruz · R01 · FY2024 · CA
Design and development of HDAC11-specific chemical inhibitors for disease treatments
$697,517Edward Seto · George Washington University · R01 · FY2023 · AI
Design and development of HDAC11-specific chemical inhibitors for disease treatments
$697,517Edward Seto · George Washington University · R01 · FY2024 · AI
Design and development of HDAC11-specific chemical inhibitors for disease treatments
$697,517Edward Seto · George Washington University · R01 · FY2022 · AI
Preclinical optimization of a parasiticidal drug for cryptosporidiosis
$697,491Christopher D Huston · University Of Vermont & St Agric College · R01 · FY2022 · AI
Leadership, Planning, and Evaluation
$697,412Stanton L Gerson · Case Western Reserve University · P30 · FY2020 · CA
Nomethiazoles harnessing GABA and NO mimetic activity for Alzheimer's therapy
$697,279Gregory R J Thatcher · Revivo Therapeutics, Inc. · R42 · FY2017 · AG
Rational design and synthesis of small molecule inhibitors targeting unique pathogenic mechanisms in Gram- and Gram+ bacteria important in UTI
$697,215James W Janetka · Washington University · U19 · FY2025 · AI
Antagonists of A2B Receptors Improve Insulin Sensitivity
$697,156Adenosine Therapeutics, Llc · R44 · FY2005 · DK
Development of Novel Inhibitors of Ganglioside Biosynthesis
$697,057Brett E Crawford · Zacharon Pharmaceuticals, Inc. · R44 · FY2008 · CA
Selective inhibitors of MLCL/CytC Peroxidase in Barth Syndrome
$697,006Valerian E Kagan · University Of Pittsburgh At Pittsburgh · R01 · FY2025 · HL
Identification of small molecules for neurological complications of HIV and substance abuse comorbidity
$696,944Pietro P Sanna · Scripps Research Institute, The · R01 · FY2018 · DA
Developing Immunotherapeutics for Methamphetamine Abuse
$696,926Thomas Richard Kosten · Baylor College Of Medicine · U01 · FY2009 · DA
Epigenetic Probes for HMTs
$696,840Haiching Ma · Reaction Biology Corporation · R44 · FY2016 · TR
Drug repurposing of a novel synthetic progestin for the prevention of preterm labor and fetal inflammation
$696,840Suhas Kallapur · University Of California Los Angeles · R01 · FY2024 · HD
Propargyl-linked Antifolates Targeting Klebsiella pneumoniae
$696,770Dennis L Wright · University Of Connecticut Storrs · R01 · FY2017 · AI
Molecular Roles of Cdk5 in Neuronal Functions and Pain Signaling
$696,702Ashok Kulkarni · National Institute Of Dental & Craniofacial Research · ZIA · FY2010 · DE
UNC-Duke Collaborative Clinical Pharmacology Postdoctoral Training Program
$696,677Kim L Brouwer · Univ Of North Carolina Chapel Hill · T32 · FY2018 · GM
COMPARATIVE GENOMICS OF PARASITIC NEMATODES
$696,640Makedonka Mitreva · Washington University · R56 · FY2019 · AI
Integrated ligand and target discovery by chemical proteomics for glioblastoma treatment.
$696,619Paul S Mischel · Stanford University · R01 · FY2021 · CA
Vascular Stiffness as a Precursor of Hypertension in a Middle-aged Cohort
$696,589Vasan S. Ramachandran · Boston University Medical Campus · R01 · FY2015 · HL